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Background and purpose: The advances in the diagnosis and treatment of acute stroke increase the impor-
tance of providing these patients with timely medical attention. This study was designed to assess time delays 
in neurological evaluation and neuroimaging and to determine whether they are important obstacles to performing 
thrombolytic therapy.
Methods: Data were obtained between May 2004 and September 2006 from 195 consecutive patients who were 
admitted to Cheju National University Hospital for acute ischemic stroke within 24 hours of the onset of symptoms. 
We determined the time of the onset of symptoms, arrival time at the emergency department (ED), and times of 
neurology notification, neurology evaluation, and neuroimaging using interviews and by reviewing the medical record. 
Results: Short onset-to-door time, performing computed tomography rather than magnetic resonance imaging, 
presence of aphasia or motor weakness, and severe initial neurological deficit were significantly associated with 
reduced in-hospital delays. Seventeen (20%) of the 85 patients who arrived within 3 hours of the onset of symptoms 
received intravenous thrombolysis. Mild neurological deficit, rapidly improving symptoms, and insufficient time to 
workup were the main causes of the nonreceipt of thrombolytic therapy in these patients. Only one patient did not 
receive thrombolytic therapy due to delay in neurology consultation. 
Conclusions: Whilst in-hospital delays were not major obstacles to performing thrombolytic therapy in this study, 
there is still a high probability of missing patients with mild-to-moderate stroke symptoms. More effective in-hospital 
organization is required for the prompt evaluation and treatment of patients with acute ischemic stroke.
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INTRODUCTION
Thrombolytic therapy with recombinant tissue plasmi-
nogen activator (rt-PA) is the only proven treatment for 
ischemic stroke, when it is administered within 3 hours 
of the onset of symptoms.
1,2 Although 15-56% of the 
patients with acute ischemic stroke arrive at the emer-
gency department (ED) within 3 hours of the onset of 
symptoms, currently only 2–8% of these patients receive 
thrombolytic therapy.
3-5 A substantial proportion of 
patients who arrive early do not receive thrombolytic 
therapy due to avoidable reasons such as delays in 
physician evaluation and neuroimaging, incorrect appli-
cation of criteria, and incorrect diagnosis.
6-9 According 
to the guidelines for identifying and treating acute 
stroke,
10 patients with acute stroke should be examined 
or notified to stroke expertise within 15 minutes of Journal of Clinical Neurology: Vol. 3, No. 2, 2007
- 72 -
arrival at the ED. A computed tomography (CT) scan 
should be performed within 25 minutes, and the specific 
drug should be infused within 60 minutes. CT has been 
the principal neuroimaging modality in many previous 
studies investigating in-hospital delays in stroke the-
rapy.
11-15 However, the development of multimodal mag-
netic resonance imaging (MRI) has led to this being 
increasingly used as the initial neuroimaging modality in 
acute stroke management. The aim of this study was to 
quantify the time delays in physician evaluation and neuro-
imaging in patients with acute stroke and to determine 
whether they are important obstacles to performing throm-
bolytic therapy.
MATERIALS AND METHODS
1. Study design, setting, and selection of participants
Cheju National University Hospital is a teaching 
university hospital located in the center of Jeju city, 
which has a population of 300,000. In our hospital, CT 
scanning is readily available 24 hours a day, but MRI 
is performed by a technologist who is not in-house from 
1800 to 0800. Currently we do not have any specific 
stroke protocol for the rapid evaluation and treatment of 
patients with acute stroke. Our hospital has an ongoing 
prospective stroke registry for patients who are admitted 
this hospital within 7 days of the onset of symptoms, 
which was implemented in May 2004. In this study, we 
limited the study population to those who presented 
within 24 hours of the onset of symptoms because this 
group of acute stroke patients would more clearly show 
the acute stroke management in our hospital. Clinical 
variables including age, sex, mode of transportation, 
referral method, and subtype of ischemic stroke, Na-
tional Institutes of Health Stroke Scale (NIHSS) score, 
vascular risk factors, and types of specific treatment 
were collected from the ongoing prospective stroke 
registry. Subtypes of ischemic stroke were determined 
according to the classification of the Trial of Org 10172 
in Acute Stroke Treatment.
16 The main symptoms of the 
patients were categorized into motor weakness, sensory 
deficit, disturbance of consciousness, aphasia, visual 
disturbance, eye movement abnormality, dizziness or 
ataxia, and headache.
2. Methods of measurement and data collection
The onset time was defined as the first time that the 
patient or an observer noticed a neurological deficit such 
as aphasia, motor weakness, or disturbance of conscious-
ness. If symptoms were present upon awakening, the 
onset time was considered as the midpoint between 
falling asleep or the last time the patient had no symp-
toms and awakening. The door-to-neurology notification 
time (DNNT) was defined as the time delay between 
arrival at the ED and the time when the ED physician 
or duty intern notified the patient to neurology. The 
door-to-neurology evaluation time (DNET) was the time 
delay between arrival at the ED and the time that 
neurologist or neurology resident examined the patient. 
The door-to-neuroimaging time (DNIT) was the time 
delay between arrival at the ER and the time that reads 
on the first image of the scan. One of the authors 
(Y.J.K.) interviewed all the patients after admission, but 
when the patient was unable to communicate due to 
aphasia or severe deficits, the interviewer collected the 
information from a family member. The exact onset 
time, referral method, method of transportation, and 
history of stroke were collected by interview. We 
investigated whether or not patients who arrived within 
3 hours of the onset of symptoms received intravenous 
thrombolytic therapy. When the patient did not receive 
the treatment, we investigated the possible reasons. 
DNNT, DNET, DNIT, and the reasons for nonreceipt of 
thrombolytic therapy were collected retrospectively using 
medical records and the stroke registry. We divided the 
patients into two groups based whether the onset-to-door 
time was less than 3 hours (group 1) or 3–24 hours 
(group 2), because this time is critical to thrombolytic 
therapy.
3. Statistical analysis
We used a descriptive analysis for general charac-
teristics of the patients. Because DNNT, DNET, and 
DNIT were not normally distributed, we used medians Choi JC, et al. In-Hospital Delays in Acute Ischemic Stroke 
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Table 1. Characteristics of the study patients.
Characteristic All patients (n=195)
Age, years, mean±SD 68.4±11.9
Gender, women, no. (%)  79 (40)
Mode of transportation (n=172)
EMS  81 (53)
Other  91 (47)
Referral method (n=187)
Direct visit  98 (61)
From general hospital  29 (18)
From primary physician  35 (22)
Initial neuroimaging modality
CT  68 (35)
CT at another hospital 17 (8)
MRI 110 (56)
Vascular risk factor
Hypertension 107 (55)
Diabetes mellitus  37 (19)
Hypercholesterolemia  31 (16)
Current smoking  28 (14)
Atrial fibrillation  39 (20)
Previous history of stroke  48 (25)
Initial NIHSS score 6.9±6.9
CT; computed tomography, EMS; emergency medical 
service, NIHSS; National Institutes of Health Stroke Scale, 
MRI; magnetic resonance imaging.
Figure 1. Admissions for acute ischemic stroke at Cheju 
National University Hospital during the study period. Times 
are relative to the onset of symptoms.
IV; intravenous, rt-PA; recombinant tissue plasminogen 
activator.
as the representative values and analyzed them using the 
Mann-Whitney  U test or Kruskal-Wallis test in relation 
to age, gender, onset-to-door time, referral method, type 
of initial neuroimaging, subtype of ischemic stroke, pre-
sence of aphasia or motor weakness, initial NIHSS 
score, and acute treatments. For the variables that 
showed significant results on univariate analysis, we 
performed linear regression analysis for DNNT, DNET, 
and DNIT. All analyses were performed using SPSS 
(version 10.0), and a probability value of p < 0.05 was 
considered to be indicative of statistical significance.
RESULTS
1. Clinical characteristics and demographic data
Between May 1, 2004 and September 30, 2006, 453 
consecutive patients with acute ischemic stroke were 
admitted to Cheju National University Hospital within 
7 days of the onset of symptoms, of which the 195 
patients (43%) who visited the ED within 24 hours 
became the subjects of this study (Table 1). Eighty-five 
patients (44%) arrived at the hospital within 3 hours of 
the onset of symptoms (Fig. 1). Eighty-nine percent of 
the patients had cerebral infarctions and 11% had 
transient ischemic attacks. Large-artery atherosclerosis 
was the most frequent stroke subtype (30%), followed 
by cardioembolism (29%), stroke of undetermined 
etiology (21%), and small-vessel occlusion (19%). 
Seventeen patients (8.7%) received intravenous throm-
bolysis, of which seven patients also underwent com-
bined intra-arterial thrombolysis. DNNT, DNET, and 
DNIT were significantly delayed in patients who arrived 
more than 3 hours after the onset of symptoms (Table 2).
2. Door-to-neurology evaluation time and door-to- 
neuroimaging time
1) Door-to-neurology notification time (Fig. 2-A)
We were unable to determine the exact time of 
notification from the medical records of 111 patients. 
Overall, 37% of the patients were notified within 15 
minutes: 51% and 27% in groups 1 and 2, respectively.Journal of Clinical Neurology: Vol. 3, No. 2, 2007
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Table 2. Values of the door-to-neurology notification time (DNNT), door-to-neurology evaluation time (DNET), and door- 
to-neuroimaging time (DNIT)
Characteristic
Group 1
(n = 85)
Group 2
(n = 110)
All patients
(n = 195)
p*
DNNT, minutes 16 (7–24) 31 (14–76) 20 (10–50) 0.001
DNET, minutes  24 (12–64)  75 (29–124)  42 (15–100) < 0.001
DNIT, minutes  44 (28–87)  64 (41–116) 56 (34–99) 0.008
Values are medians and interquartile ranges.
*Group 1 vs. group 2 by Mann-Whitney U test.
(A)
(B)
(C)
Figure 2. Cumulative percentages of the patients according 
to values of the DNNT (A), DNET (B), and DNIT (C).
2) Door-to-neurology evaluation time (Fig. 2-B)
Twenty-six percent of the patients received a neuro-
logy evaluation by a neurology resident or a neurologist 
within 15 minutes of arrival at the ED. The median time 
between notification and neurology evaluation was 10 
minutes for group 1 and 20 minutes for group 2.
3) Door-to-neuroimaging time (Fig. 2-C)
Seventeen patients who were referred from another 
general hospital after performing CT were excluded 
from the analysis. Overall, CT or MRI was performed 
within 25 minutes in only 15% of the patients. Seven-
teen percent of the patients in group 1 underwent neuro-
imaging within 25 minutes, even though they arrived at 
the ED within 3 hours of the onset of symptoms. The 
median time delays to performing CT and MRI were 34 
and 69 minutes, respectively.
4) Univariate analysis
The onset-to-door time (dichotomized into within 
3 hours and longer), type of initial neuroimaging (CT or 
MRI), presence of aphasia or motor weakness, and 
initial NIHSS score were significantly associated with 
DNNT, DNET, and DNIT (Table 3).
5) Multivariate analysis
Because DNNT, DNET, and DNIT did not exhibit 
normal distributions, we used their natural logarithmic 
values as dependent variables. Age, gender, and all other 
factors that showed significant results from univariate 
analysis were included in the multivariate analysis. The 
adjusted values of R2 for DNNT, DNET, and DNIT 
were 0.315, 0.218, and 0.222, respectively. The onset-to- 
door time, type of the initial neuroimaging, and initial 
NIHSS score significantly affected DNIT (Table 4).Choi JC, et al. In-Hospital Delays in Acute Ischemic Stroke 
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Table 3. Factors related to DNNT, DNET, and DNIT: univariate analysis
DNNT DNET DNIT
Onset-to-door time ‡‡†
0-3 hours 16 (7–24)  24 (12–64) 44 (28–87)
3-24 hours  27 (14–76)   75 (29–124)  64 (41–116)
Mode of transportation  *
EMS 16 (9–45)  35 (15–86) 44 (28–78)
Other  20 (13–45)   50 (19–117) 61 (39–99)
Initial neuroimaging modality  * †‡
CT  35 (16–80)   69 (29–107) 34 (24–56)
MRI 19 (9–38)  36 (15–90)   70  (46–118)
CT at another hospital 6 (1–11) 14 (0–75)
Aphasia †††
Yes 11 (5–20)  25 (14–42) 38 (26–52)
No  25 (10–67)   55 (17–108)  58 (34–107)
Motor weakness * * †
Yes  17 (10–34)  35 (14–85) 52 (31–77)
No  37 (14–80)   71 (26–120)  58 (35–123)
Initial NIHSS score †‡‡
0-3  30 (17–71)   67 (33–109)  71 (46–127)
4-7 19 (7–58)    50 (19–129) 58 (39–87)
8-14  20 (11–35)  30 (11–85) 47 (26–84)
> 14 10 (5–16) 15 (5–48) 32 (22–48)
Values (in minutes) are medians and interquartile ranges.
*p < 0.05, 
†p < 0.01, 
‡p < 0.001 within the diagnostic groups as measured by a Mann-Whitney U test or Kruskal-Wallis test.
Table 4. Factors related to DNNT, DNET, and DNIT: multivariate analysis
Variable B tp
Age  0.012  2.448 0.015
Gender -0.165 -1.378 0.170
Initial NIHSS score -0.034 -3.663 0.000
Motor weakness 0.054  0.455 0.650
Aphasia 0.057  0.331 0.741
Onset-to-door time 0.029  3.319 0.001
Neuroimaging 0.519  4.624 0.000
B is the unstandardized coefficient, and t represents B divided by the standard error.
Age, onset-to-door time (in hours), and NIHSS score were analyzed as continuous variables. Gender, motor weakness (yes/no), 
aphasia (yes/no), and neuroimaging modality (CT/MRI) were entered as dichotomous variables.
3. Rate of receiving thrombolytic therapy
Seventeen (20%) of the 85 patients who arrived 
within 3 hours of the onset of symptoms received 
intravenous thrombolysis. The mean and median times 
from ED arrival to infusion (the door-to-needle time) 
were 76 and 80 minutes, respectively. Six patients (35%) 
received thrombolytic therapy within 60 minutes, and 
this increased to 15 patients (94%) within 120 minutes. 
Most of the remaining 68 patients who did not receive 
thrombolytic therapy were excluded due to mild neuro-
logical deficit (NIHSS score ≤ 4), rapidly improving 
symptoms, insufficient time to workup, and other un-
avoidable reasons. Eight patients did not receive the 
treatment due to avoidable reasons including incorrect 
application of criteria and not obtaining informed consent, 
with the reason being delay in neurology consultation in 
one case (Table 5).Journal of Clinical Neurology: Vol. 3, No. 2, 2007
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Table 5. Reasons for nonreceipt of thrombolytic treatment (n  = 68)
Reason Number
Unavoidable or absolute contraindications*
Minor symptoms (NIHSS score ≤ 4) 43
Rapidly resolving symptoms  6
Time limit (arrival > 150 minutes after onset of symptoms)  6
Recent ischemic stroke  2
Extensive CT changes  3
International normalized ratio > 1.7  1
Recent subdural hemorrhage  1
Subtotal 62
Avoidable reasons or no documented contraindication
Incorrect application of exclusion criteria  6
Informed consent could not be obtained  1
Delayed neurology consultation  1
Subtotal  8
*Some patients had more than one exclusion.
DISCUSSION
This study revealed considerable in-hospital delays 
in neurology evaluation and neuroimaging relative to 
suggested guidelines. Overall, 37% of the patients were 
notified within 15 minutes, and only 26% of the patients 
received a neurology evaluation by a neurology resident 
or a neurologist within 15 minutes of arrival at the ED. 
Neuroimaging started within 25 minutes in only 15% of 
the patients. Only 8.7% and 20% of ischemic stroke 
patients who visited an ED within 24 hours and within 
3 hours of the onset of symptoms, respectively, received 
rt-PA. Most patients who arrived early were excluded 
from thrombolytic therapy due to the presence of un-
avoidable reasons or absolute contraindications. 
Previous studies found that minor neurologic deficits 
and rapidly improving symptoms were important reasons 
for the nonreceipt of thrombolytic therapy by patients 
who arrived early after the onset of symptoms. Other 
frequently reported absolute contraindications have been 
recent stroke, presence of intracerebral hemorrhage, 
bleeding tendency, high blood pressure, and early CT 
changes.
5-9 However, 24-26% of patients reportedly did 
not receive thrombolytic therapy due to avoidable rea-
sons such as delays in neurology evaluation or neuro-
imaging, incorrect diagnoses, and incorrect application of 
criteria.
6-8 In the present study, in 12% of cases the 
patients did not receive thrombolytic therapy due to 
avoidable reasons such as incorrect application of 
criteria, not obtaining informed consent, and delayed 
neurology consultation. Although this represents a re-
latively small proportion of the patients, such avoidable 
factors are very important in acute-stroke management 
because, unlike absolute or unavoidable reasons, these 
problems can be resolved by educating personnel and 
making changes to hospital procedures.
The reported DNET and DNIT have varied greatly 
between studies due to different conditions, but many 
researchers have found that the severity of neurological 
deficit, use of an emergency medical service (EMS), and 
short onset-to-door time were significantly associated 
with reducing DNET or DNIT.
11-15,17  The severity of 
neurological deficit and onset-to-door time also sig-
nificantly affected DNET and DNIT in the present 
study. Fifty-three percent of the patients used an EMS 
in this study. Although such use tended to reduce the 
onset-to-door time, DNET, and DNIT, the difference did 
not reach statistical significance, possibly because an 
EMS was used more frequently by patients who arrived 
later in this study. 
MRI is more sensitive than CT in diagnosing acute 
ischemic stroke and is also useful for detecting hemo-
rrhage.
18,19 Multimodal MRI can provide more details of Choi JC, et al. In-Hospital Delays in Acute Ischemic Stroke 
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ischemic tissue and thus may lengthen therapeutic win-
dows in the acute treatment of ischemic stroke without 
increasing the incidence of cerebral hemorrhage.
20 How-
ever, it is generally more expensive, time-consuming, 
and requires more knowledge for accurate interpreta-
tions. MRI was the initial neuroimaging modality in 
56% of the patients in this study, and the rate of 
performing MRI did not differ significantly between 
patients who arrived within 3 hours of the onset of 
symptoms and those who arrived later than 3 hours. 
However, the median time delays to performing CT and 
MRI were 34 and 69 minutes, respectively, and the 
use of MRI significantly increased DNIT. Five of the 
17 patients who received thrombolytic therapy under-
went MRI as their initial neuroimaging modality, and 
the door-to-imaging time did not differ significantly 
between CT and MRI in these patients. However, 
screening all the patients with MRI before thrombolytic 
treatment would significantly delay neuroimaging be-
cause in our hospital MRI is performed by a techno-
logist who is not present during the nighttime. The 
availability of MRI 24 hours a day reportedly results 
in no difference in the door-to-imaging time between 
CT and MRI.
18,21
Despite the presence of such prominent in-hospital 
delays, only a small proportion of our patients were 
excluded from thrombolytic therapy due these delays 
or other avoidable reasons. Because most patients who 
received thrombolytic therapy had severe neurological 
deficits (mean initial NIHSS score = 14.29), they were 
evaluated more rapidly than other patients. However, if 
patients present with only mild-to-moderate stroke 
symptoms (e.g., NIHSS score of 5‒14), they may not 
receive thrombolytic therapy due to delays in physician 
evaluation and neuroimaging. Because stroke treatment 
is more effective when it is initiated earlier, we should 
therefore attempt to reduce door-to-physician evaluation 
or neuroimaging time as well as onset-to-door time. The 
main problem of the current system at our hospital 
is that DNET and DNIT are greatly affected by the 
severity of the stroke. Therefore, we need to organize 
our stroke team and develop a specific protocol so that 
every acute-stroke patient receives rapid evaluation and 
treatment.
This study was subject to several limitations. First, the 
study was performed at a single center, which may limit 
the generalizability of its findings. Second, we obtained 
all the in-hospital data retrospectively and many data on 
neurology notifications were not available. Because the 
purpose of this study was to quantify time delays in 
physician evaluation and neuroimaging at our hospital 
and to provide baseline data for organizing the stroke 
team and developing a specific protocol, DNET and 
DNIT might have been shorter (and more accurate) if 
we had collected the data prospectively. Third, the 
overall multivariate statistical models for DNET and 
DNIT showed only moderate correlations, suggesting 
that significant predictive variables were omitted from 
the analyses.
In conclusion, we found significant delays in neuro-
logy evaluation and neuroimaging of patients with acute 
ischemic stroke in this study. Although such in-hospital 
delays were not major obstacles to performing throm-
bolytic therapy, there is a greater probability of missing 
patients with mild-to-moderate stroke symptoms. More 
effective in-hospital organization is required to ensure 
the prompt evaluation and treatment of patients with 
acute ischemic stroke.
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